Synthesis and biological evaluation of ortho-aryl N-hydroxycinnamides as potent histone deacetylase (HDAC) 8 isoform-selective inhibitors (Q39294035)

10 September 2017

title

Synthesis and biological evaluation of ortho-aryl N-hydroxycinnamides as potent histone deacetylase (HDAC) 8 isoform-selective inhibitors (English)

1 reference

10 September 2017

1 reference

10 September 2017

1 reference

10 September 2017

Liang-Chieh Chen

0 references

Wei-Jan Huang

1 reference

10 September 2017

Yi-Ching Wang

1 reference

10 September 2017

Shi-Wei Chao

1 reference

10 September 2017

Chen-Yui Yang

1 reference

10 September 2017

Mei-Hsiang Lin

1 reference

10 September 2017

Mei-Yu Chen

1 reference

10 September 2017

Tai-Lin Lee

1 reference

10 September 2017

Ping Yang

1 reference

10 September 2017

publication date

20 August 2012

1 reference

10 September 2017

1 reference

10 September 2017

1 reference

10 September 2017

1 reference

10 September 2017

page(s)

1815-1824

1 reference

Dissecting the biological functions of Drosophila histone deacetylases by RNA interference and transcriptional profiling.

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200300

A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200300

Development of the pan-DAC inhibitor panobinostat (LBH589): successes and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200300

SB939, a novel potent and orally active histone deacetylase inhibitor with high tumor exposure and efficacy in mouse models of colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200300

HDAC inhibitor PCI-24781 decreases RAD51 expression and inhibits homologous recombination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200300

Preclinical antileukemia activity of JNJ-26481585, a potent second-generation histone deacetylase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200300

The histone deacetylase inhibitor ITF2357 reduces production of pro-inflammatory cytokines in vitro and systemic inflammation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200300

Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200300

A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200300

The histone deacetylase inhibitor MGCD0103 induces apoptosis in B-cell chronic lymphocytic leukemia cells through a mitochondria-mediated caspase activation cascade.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200300

Isoform-specific histone deacetylase inhibitors: the next step?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200300

Histone deacetylase inhibitors: from bench to clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200300

Role of Class I and Class II histone deacetylases in carcinoma cells using siRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200300

A novel histone deacetylase 8 (HDAC8)-specific inhibitor PCI-34051 induces apoptosis in T-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200300

Expression of histone deacetylase 8, a class I histone deacetylase, is restricted to cells showing smooth muscle differentiation in normal human tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200300

Targeting of HDAC8 and investigational inhibitors in neuroblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200300

Targeting histone deacetylases in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200300

The inv(16) fusion protein associates with corepressors via a smooth muscle myosin heavy-chain domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200300

Azetidinones as zinc-binding groups to design selective HDAC8 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200300

Identification of novel isoform-selective inhibitors within class I histone deacetylases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200300

Discovery of histone deacetylase 8 selective inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200300

On the inhibition of histone deacetylase 8

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200300

A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200300

Isolation and Characterization of cDNAs Corresponding to an Additional Member of the Human Histone Deacetylase Gene Family

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200300

Three proteins define a class of human histone deacetylases related to yeast Hda1p

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200300

Cloning and functional characterization of HDAC11, a novel member of the human histone deacetylase family

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200300

A fluorogenic histone deacetylase assay well suited for high-throughput activity screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200300

Histone deacetylase HDAC8 associates with smooth muscle alpha-actin and is essential for smooth muscle cell contractility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200300

inferred from DOI database lookup

7 January 2021

based on heuristic

Design and evaluation of 'Linkerless' hydroxamic acids as selective HDAC8 inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201200300

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/CMDC.201200300

1 reference

10 September 2017

1 reference